Lipid-Lowering Drugs and Risk of New-Onset Diabetes: A Cohort Study Using Japanese Healthcare Data Linked to Clinical Data for Health Screening

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2017-015935
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Impact of Lipid-Lowering Therapy on Glycemic Control and the Risk for New-Onset Diabetes Mellitus

Drugs in Context
Molecular MedicinePharmacology
2018English

Using Clinical Trial Data and Linked Administrative Health Data to Reduce the Risk of Adverse Events Associated With the Uptake of Newly Released Drugs by Older Australians: A Model Process

BMC Public Health
EnvironmentalPublic HealthOccupational Health
2011English

Screening for Impaired Fasting Glucose and Diabetes Using Available Health Plan Data

Journal of Diabetes and its Complications
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Epidemiology of Pulmonary Fibrosis: A Cohort Study Using Healthcare Data in Sweden

Pulmonary Therapy
2019English

Cancer Risk in Chinese Diabetes Patients: A Retrospective Cohort Study Based on Management Data

Endocrine Connections
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Diabetes Shared Care Program (DSCP) and Risk of Infection Mortality: A Nationwide Cohort Study Using Administrative Claims Data in Taiwan

BMJ Open
Medicine
2018English

For Better Healthcare Mining Health Data

Intelligent Multidimensional Data Clustering and Analysis
2017English

Lipid-Lowering Drugs (Statins) and Peripheral Neuropathy

Electronic Physician
2018English

What Factors Contribute to Positive Early Childhood Health and Development in Australian Aboriginal Children? Protocol for a Population-Based Cohort Study Using Linked Administrative Data (The Seeding Success Study)

BMJ Open
Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy